Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 2/3 1Phase 1 1

Status

Completed 5Unknown 2Terminated 1Recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 8Genitourinary 7Lymphoid 6Endocrine 6NET 5Breast 5Tumor-Agnostic 3Thoracic 3Head & Neck 3CNS 3Plasma cell 1Other hematologic neoplasm 1Gynecologic 1Classical hematology 1

Conditions

Neuroendocrine Tumors 5

Interventions

Everolimus 19lutetium Lu 177 dotatate 8Octreotide 8lanreotide 7pasireotide 6Temozolomide 6Sunitinib 6pembrolizumab 5gallium Ga 68 dotatate 5Positron Emission Tomography Computed Tomography 5surufatinib 4Sorafenib 4Data Collection 4Carboplatin 43-Iodobenzylguanidine 4Positron-Emission Tomography 3Nivolumab 3Magnetic Resonance Spectroscopy 3Etoposide 3Capecitabine 390Y-octreotide, DOTA-Tyr(3)- 3pentetreotide 2pazopanib 2lenvatinib 2fosbretabulin 2fluorodopa F 18 2cabozantinib 2avelumab 2arginyllysine 2Single Photon Emission Computed Tomography Computed Tomography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Positron Emission Tomography Computed Tomography × NET × Clear all
NCT04510311 2025-01-10

Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Completed
32 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT03271281 2022-06-30

PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2

Rigshospitalet, Denmark

Phase 2 Completed
113 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT03278275 2022-06-30

PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105

Rigshospitalet, Denmark

Phase 2 Completed
116 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT04552847 2022-02-17

Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors

Universitaire Ziekenhuizen KU Leuven

Phase 2/3 Completed
85 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT03883776 2020-09-09

Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors

Universitaire Ziekenhuizen KU Leuven

Phase 1 Completed
12 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡